Further economic analyses are warranted to support sustainable implementation
Noncirrhotic MASH with Moderate to Advanced Liver Fibrosis in Adults The recommended maintenance dosage of WEGOVY injection for the treatment of noncirrhotic MASH with moderate to advanced liver fibrosis in adults is 2.4 mg injected subcutaneously once weekly
10.1111/adb.12295 101 VallfD.VestlundJ.JerlhagE
[19] What Could Change Coverage State-Level Changes to Watch California (CalPERS): Transitioned from OptumRx to CVS Caremark on January 1, 2026state employees should verify new formulary status [23] Indiana: State employee plans now exclude all GLP-1s for weight loss (not just Zepbound) effective January 1, 2026 [24] Wyoming: Launched new CVS Caremark weight management program with GLP-1 access via enrollment (January 2026) [25] For Medicare policy updates, see our Medicare guide
Archives of Rheumatology , 37(2), 212-222
As a registered nurse, Kyle brings clinical expertise to every treatment and is passionate about making IV therapy accessible and convenient for LA residents